Physician profile
Monzer Chehab
NPI 1629365184
$2,355.37
in general payments reported to CMS, 2019-2025
25 companies · $476 in 2025
The $476 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $13.25 · 2021: $534 · 2022: $297 · 2023: $305 · 2024: $549 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $525.95 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $435.26 | 2021-2025 | Embold Fibered, Ranger, Ekosonic |
| Stryker Corporation | $200.12 | 2019-2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $169.04 | 2024 | Endocross Device, Torus Stent Graft System |
| Cardiovascular Systems INC. | $164.14 | 2019-2023 | Diamondback Peripheral |
| Cook Medical LLC | $150.31 | 2023-2025 | Tornado, Cook Celect, Zilver Ptx |
| Getinge USA Sales, LLC | $119.81 | 2019-2024 | Icast, Flixene |
| Sirtex Medical INC | $107.63 | 2023-2024 | Sir-Spheres Microspheres |
| Abbott Laboratories | $100.63 | 2022-2024 | Jeti All In One Non-Sterile Kit |
| Shockwave Medical, INC | $56.95 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $49.41 | 2022-2023 | |
| Medtronic, INC. | $43.56 | 2023-2024 | Kyphon Express II Kyphopak Tray, Abre |
| Heartflow, INC. | $24.35 | 2023 | Ffrct |
| Chiesi USA, INC. | $22.95 | 2025 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $20.59 | 2023 | Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $20.28 | 2019 | |
| Avinger INC. | $19.37 | 2022 | |
| Teleflex LLC | $18.52 | 2024 | Supercross |
| Cordis US Corp. | $17.42 | 2024 | Mynx Control |
| Astrazeneca Pharmaceuticals LP | $16.60 | 2022 | |
| Pfizer INC. | $16.18 | 2024 | |
| Penumbra, INC. | $16.05 | 2023 | Indigo System |
| Bard Peripheral Vascular, INC. | $14.78 | 2025 | Venovo |
| Medtronic Vascular, INC. | $13.25 | 2020 | |
| Angiodynamics, INC. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monzer Chehab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.